SLCO1A2 and breast cancer: Using T47-D breast carcinoma cells, the PXR inducer rifampicin resulted in a significant increase in OATP1A2 expression and a concomitant accumulation of intracellular E1S, which was correlated with promoted breast cancer cell proliferation in vitro [79].